Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Update: Why monitoring Typing Cadence may help detect early Parkinson’s and Alzheimer’s Disease

Above: Pat­tern of Typ­ing Cadence in 52-year-old male with Parkin­son’s. Source: Neu­raMetrix

_____

Time for Sharp­Brains’ first eNewslet­ter in 2018, offer­ing a fas­ci­nat­ing sneek peek into the rapid­ly grow­ing toolk­it to mea­sure and improve brain health.

(And don’t miss the fun teas­er at the end!)

New thinking:

New research:

New tools:

 

 

Final­ly, a quick brain teas­er. What do you see first, ani­mals or peo­ple?

 

Have a great month of Feb­ru­ary!

With pharma exiting Alzheimer’s research, new hope (and urgency) seen in the combination of brain training and transcranial direct current stimulation (tDCS)

___

What does the future hold for the war on Alzheimer’s? (The Globe and Mail):

After spend­ing huge sums on clin­i­cal trails in recent years, the phar­ma­ceu­ti­cal indus­try has failed to find a drug that can halt the mind-rob­bing dis­ease. And this month, Pfiz­er announced it is end­ing its Alzheimer’s research, although oth­er com­pa­nies haven’t thrown in the tow­el yet. But oth­er pre­ven­tion mea­sures are being explored.

Sev­er­al Toron­to hos­pi­tals are involved in an ambi­tious $10-mil­lion, five-year study to deter­mine whether a com­bi­na­tion of cog­ni­tive reme­di­a­tion – men­tal exer­cis­es – plus elec­tri­cal stim­u­la­tion of the brain can delay Read the rest of this entry »

UCSF, Stanford, VieLight & Lumos Labs at the frontier of brain health & enhancement

On Decem­ber 7th select­ed Sum­mit Spon­sors and Part­ners show­cased their most promis­ing brain health & enhance­ment ini­tia­tives and solu­tions.

At the fron­tier with Neu­roscape, VR/ AR and Pho­to­bio­mod­u­la­tion (record­ings require reg­is­tra­tion; view slid­edeck for all am ses­sions Here)

  • Adam Gaz­za­leyUCSF Pro­fes­sor of Neu­rol­o­gy, presents Neu­roscape
  • Dr. Wal­ter Green­leaf, Med­ical VR/ AR Expert at Stan­ford Vir­tu­al Human Inter­ac­tion Lab, pro­vides an overview of health appli­ca­tions of vir­tu­al & aug­ment­ed real­i­ty (VR/AR)
  • Dr. Lew Lim, Founder & CEO of Vielight, dis­cuss­es pho­to­bio­mod­u­la­tion as a new way to enhance brain func­tion

Dr. Bob Schafer, Direc­tor of Research at Lumos Labs, presents their expand­ing vision for brain train­ing, includ­ing mind­ful­ness.

Slid­edeck sup­port­ing ses­sion held dur­ing the 2017 Sharp­Brains Vir­tu­al Sum­mit: Brain Health & Enhance­ment in the Dig­i­tal Age (Decem­ber 5–7th). All ses­sion record­ings avail­able for pur­chase (50+ Speak­ers, 15+ Hours, $150).

How will the Clinicians, Patients and Consumers of the Future ensure appropriate use of brain enhancement methods encompassing lifestyle, supplements, brain training, meditation, bio/ neurofeedback, tDCS and more?

How will the Clin­i­cians, Patients and Con­sumers of the Future ensure appro­pri­ate use of brain enhance­ment meth­ods encom­pass­ing lifestyle, sup­ple­ments, brain train­ing, med­i­ta­tion, bio/ neu­ro­feed­back, tDCS and more? (record­ing requires reg­is­tra­tion; view slid­edeck above or Here)

  • Dr. Eddie Mar­tuc­ci, Co-Founder and CEO of Akili Inter­ac­tive Labs
  • Dr. Anna Wexler, sci­ence writer, film­mak­er and post­doc fel­low at the Depart­ment of Med­ical Ethics and Health Pol­i­cy at UPenn’s Perel­man School of Med­i­cine
  • Dr. Olivi­er Oul­li­er, Pres­i­dent of EMOTIV 
  • Dr. Peter Rein­er, Co-Founder of the Nation­al Core for Neu­roethics at the Uni­ver­si­ty of British Colum­bia
  • Chaired byDr. Ali­son Fen­ney, Exec­u­tive Direc­tor of the Neu­rotech­nol­o­gy Indus­try Orga­ni­za­tion (NIO)

Slid­edeck above sup­port­ed ses­sion held dur­ing the 2017 Sharp­Brains Vir­tu­al Sum­mit: Brain Health & Enhance­ment in the Dig­i­tal Age (Decem­ber 5–7th).

Pending FDA review and approval, research findings pave way for Akili’s EVO to become first brain training platform prescribed for ADHD

Akili Achieves Pri­ma­ry Effi­ca­cy End­point in ADHD Tri­al (MD mag­a­zine):

Boston-based Akili Inter­ac­tive has announced top-line results from the STARS-ADHD piv­otal study of its inves­ti­ga­tion­al dig­i­tal ther­a­peu­tic med­i­cine AKL-T01, in treat­ment of pedi­atric atten­tion-deficit/hy­per­ac­tiv­i­ty dis­or­der (ADHD)…The dig­i­tal med­i­cine, AKL-T01, is a video game for patients to play on tablet devices. It uses the same sto­ry­telling and reward mech­a­nisms as stan­dard videogames; how­ev­er, it fea­tures mech­a­nisms to act on neur­al sys­tems and algo­rithms that dial the lev­el of stim­u­lus up or down, meet­ing the needs of the patient. Read the rest of this entry »

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Search in our archives

Follow us and Engage via…

twitter_logo_header
RSS Feed

Watch All Recordings Now (40+ Speakers, 12+ Hours)

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.